[go: up one dir, main page]

NO20026197D0 - Fremgangsmåte for fremstilling av en blanding - Google Patents

Fremgangsmåte for fremstilling av en blanding

Info

Publication number
NO20026197D0
NO20026197D0 NO20026197A NO20026197A NO20026197D0 NO 20026197 D0 NO20026197 D0 NO 20026197D0 NO 20026197 A NO20026197 A NO 20026197A NO 20026197 A NO20026197 A NO 20026197A NO 20026197 D0 NO20026197 D0 NO 20026197D0
Authority
NO
Norway
Prior art keywords
preparing
solution
homogeneous dispersion
compositions
mixture
Prior art date
Application number
NO20026197A
Other languages
English (en)
Other versions
NO20026197L (no
NO332181B1 (no
Inventor
Patrick Busson
Marco Schroeder
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8169074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20026197(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20026197D0 publication Critical patent/NO20026197D0/no
Publication of NO20026197L publication Critical patent/NO20026197L/no
Publication of NO332181B1 publication Critical patent/NO332181B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20026197A 2000-06-27 2002-12-23 Preparat samt fremgangsmate for fremstilling av preparat NO332181B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00113535 2000-06-27
PCT/EP2001/006834 WO2002000201A2 (en) 2000-06-27 2001-06-18 Method for preparing a composition

Publications (3)

Publication Number Publication Date
NO20026197D0 true NO20026197D0 (no) 2002-12-23
NO20026197L NO20026197L (no) 2002-12-23
NO332181B1 NO332181B1 (no) 2012-07-16

Family

ID=8169074

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20026197A NO332181B1 (no) 2000-06-27 2002-12-23 Preparat samt fremgangsmate for fremstilling av preparat

Country Status (37)

Country Link
US (3) US6534087B2 (no)
EP (1) EP1296656B1 (no)
JP (2) JP4149803B2 (no)
KR (1) KR100557845B1 (no)
CN (1) CN1236764C (no)
AR (1) AR029278A1 (no)
AT (1) ATE334662T1 (no)
AU (2) AU2001281846B2 (no)
BR (1) BRPI0112014B1 (no)
CA (1) CA2411153C (no)
CY (1) CY1105714T1 (no)
CZ (1) CZ301813B6 (no)
DE (1) DE60121953T2 (no)
DK (1) DK1296656T3 (no)
EC (1) ECSP024401A (no)
EG (1) EG24141A (no)
ES (1) ES2269441T3 (no)
HR (1) HRP20021009B1 (no)
HU (1) HU229550B1 (no)
IL (2) IL153282A0 (no)
JO (1) JO2247B1 (no)
MA (1) MA26922A1 (no)
ME (1) ME00672B (no)
MX (1) MXPA02012583A (no)
MY (1) MY129798A (no)
NO (1) NO332181B1 (no)
NZ (1) NZ523024A (no)
PE (1) PE20020101A1 (no)
PL (1) PL203804B1 (no)
PT (1) PT1296656E (no)
RU (1) RU2244542C2 (no)
SI (1) SI1296656T1 (no)
TW (1) TWI278325B (no)
UY (1) UY26799A1 (no)
WO (1) WO2002000201A2 (no)
YU (1) YU96602A (no)
ZA (1) ZA200209649B (no)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
JP4149803B2 (ja) * 2000-06-27 2008-09-17 エフ．ホフマン−ラ ロシュ アーゲー 組成物の調製方法
US20030027786A1 (en) * 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
DE60330764D1 (de) * 2002-04-26 2010-02-11 Hoffmann La Roche Pharmazeutische zusammensetzung enthaltend einen lipase - inhibitor und glucomannan
KR100517072B1 (ko) * 2002-11-25 2005-09-26 주식회사 태평양 폴리올/고분자 마이크로캡슐 및 이를 이용한 효소 안정화방법
US9174176B2 (en) * 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
WO2005055921A2 (en) * 2003-12-12 2005-06-23 Eran Eilat Compositions for treatment of ear disorders and methods of use thereof
EP1737405A2 (en) * 2004-04-06 2007-01-03 RPG Life Sciences Limited Mouth dissolvable and meltable, and water dispersable delivery formulation
US7398161B2 (en) * 2004-09-15 2008-07-08 Banyu Pharmaceutical Co., Ltd. Sampling method and sampling device, and logD measuring method and logD measuring system
CA2593728A1 (en) * 2004-12-31 2006-07-13 Mikhail Yurievich Gotovskiy Magnetoresonance preparations, device for individually selecting said preparations for increasing an organism life activity in actual environmental conditions
US20060198856A1 (en) * 2005-03-01 2006-09-07 Keith Whitehead Ibuprofen suspension stabilized with docusate sodium
WO2006110809A2 (en) * 2005-04-12 2006-10-19 Elan Pharma International, Limited Nanoparticulate lipase inhibitor formulations
US7984717B2 (en) * 2005-04-29 2011-07-26 Medtronic, Inc. Devices for augmentation of lumen walls
WO2006138431A2 (en) * 2005-06-16 2006-12-28 Eastman Chemical Company Methods and pharmaceutical formulations for increasing bioavailability
WO2006136196A1 (en) * 2005-06-21 2006-12-28 V. Mane Fils Gellan seamless breakable capsule and process for manufacturing thereof
WO2006136197A1 (en) 2005-06-21 2006-12-28 V. Mane Fils Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule
US20070048364A1 (en) * 2005-08-04 2007-03-01 Yingxu Peng Free flowing granules containing carbomer
KR100669497B1 (ko) * 2005-08-17 2007-01-16 보람제약주식회사 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법
AR056499A1 (es) * 2005-09-06 2007-10-10 Serapis Farmaceuticals Ltd Compuestos
CN101340884A (zh) 2005-10-19 2009-01-07 曼尼·马纳舍·辛格尔 用于治疗多汗症的方法
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
ES2470340T3 (es) 2005-12-28 2014-06-23 Advanced Bionutrition Corporation Vehículo de administración para bacterias probi�ticas que comprende una matriz seca de polisac�ridos, sac�ridos y polioles en forma vítrea
FR2895908B1 (fr) * 2006-01-12 2008-03-28 France Etat Procede de fabrication d'une forme pharmaceutique de phosphate d'oseltamivir
CA2642952C (en) 2006-02-20 2014-09-02 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition comprising oseltamivir phosphate
US7903256B2 (en) 2006-03-16 2011-03-08 Duke University Methods, systems, and computer program products for performing real-time quadrature projection based Fourier domain optical coherence tomography
CN1820744B (zh) 2006-04-04 2011-01-26 中国人民解放军军事医学科学院毒物药物研究所 磷酸奥司他韦颗粒剂及其制备方法
EP1872777A1 (en) * 2006-06-27 2008-01-02 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising tetrahydrolipstatin
KR100812824B1 (ko) 2006-09-27 2008-03-12 주식회사 제닉 키토산과 폴리에틸렌글리콜을 이용한 생체친화성 저독성필름
US8460726B2 (en) 2006-12-18 2013-06-11 Advanced Bionutrition Corporation Dry food product containing live probiotic
RU2482841C2 (ru) * 2007-05-18 2013-05-27 ТиТиАй Эллебо, Инк. Устройства для трансдермальной доставки, обеспечивающие улучшенное высвобождение действующего начала через биологическую поверхность
KR101439470B1 (ko) * 2007-05-22 2014-09-16 한미사이언스 주식회사 오를리스타트 및 대변 연화제를 포함하는 비만의 예방 또는치료용 조성물
WO2009050720A1 (en) * 2007-10-15 2009-04-23 Inventis Dds Pvt Limited Pharmaceutical composition of orlistat
PL216542B1 (pl) 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
GB0900551D0 (en) * 2009-01-14 2009-02-11 Horton Richard Ingestible compositions and processes of preparation
CA2986751A1 (en) 2009-03-27 2010-09-30 Intervet International B.V. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
AU2010254235B2 (en) 2009-05-26 2015-04-02 Advanced Bionutrition Corporation Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
AU2010301135A1 (en) * 2009-09-29 2012-04-12 Michael Burnet Novel pesticide formulations
KR100940745B1 (ko) * 2009-10-15 2010-02-04 광동제약 주식회사 오를리스타트 및 아타풀지트 함유 복합제의 코팅펠렛 및 이를 이용한 제제
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
WO2011094469A2 (en) 2010-01-28 2011-08-04 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
KR101021030B1 (ko) * 2010-03-25 2011-03-09 엘지이노텍 주식회사 형광체 코팅방법, 발광장치 제조방법 및 코팅된 형광체
WO2011126030A1 (ja) * 2010-04-07 2011-10-13 三菱瓦斯化学株式会社 保存安定性に優れたｓ－アデノシル－ｌ－メチオニン含有乾燥酵母組成物及びその製造方法
EP2603100B1 (en) 2010-08-13 2018-04-25 Advanced BioNutrition Corp. Dry storage stabilizing composition for biological materials
CN103228266B (zh) * 2010-10-29 2017-11-14 健康科学西部大学 三元混合物制剂
AU2012229476B2 (en) 2011-03-01 2016-02-25 The Procter & Gamble Company Porous disintegratable solid substrate for personal health care applications
CN104244985A (zh) 2012-03-23 2014-12-24 先进生物营养公司 生物材料的稳定化组合物
CN103222964B (zh) * 2013-01-29 2014-10-08 青岛大学 一种奥利司他口服制剂及其制备方法
GB2524496A (en) * 2014-03-24 2015-09-30 British Airways Plc Dynamic tracking and control of passenger travel progress
US10851399B2 (en) 2015-06-25 2020-12-01 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
US9938558B2 (en) 2015-06-25 2018-04-10 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
JP6839666B2 (ja) 2015-06-25 2021-03-10 ネイティブ マイクロビアルズ， インコーポレイテッド 複雑な異種群集由来微生物株の解析、機能的な関係及びそれらの相互作用の予測及び同定、ならびにそれに基づく微生物アンサンブルの選択及び合成のための方法、装置、及びシステム
ES2881809T3 (es) 2015-07-29 2021-11-30 Advanced Bionutrition Corp Composiciones probióticas secas estables para usos dietéticos especiales
JP6778051B2 (ja) * 2016-08-18 2020-10-28 沢井製薬株式会社 オセルタミビルリン酸塩含有医薬組成物
US12018313B2 (en) 2016-12-28 2024-06-25 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities with tracer analytics, determination of functional relationships and interactions thereof, and synthesis of microbial ensembles
JP2020504620A (ja) 2016-12-28 2020-02-13 アスカス バイオサイエンシーズ， インコーポレイテッド 複雑な不均一コミュニティの完全微生物株の解析、その機能的関連性及び相互作用の決定、ならびにそれに基づく生物反応性の改変剤の同定及び合成、のための方法、装置、及びシステム
WO2019069108A1 (en) * 2017-10-04 2019-04-11 Debreceni Egyetem SOLID GALENIC FORM, MOLDED, GASTRIC RETENTION AND EXTENDED RELEASE AND METHOD OF PREPARING THE SAME

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
US4489438A (en) * 1982-02-01 1984-12-18 National Data Corporation Audio response system
CA1247547A (en) 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
JP3069458B2 (ja) 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
US5560921A (en) 1992-06-01 1996-10-01 The Procter & Gamble Company Chewable decongestant compositions
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
WO1994018951A1 (en) * 1993-02-23 1994-09-01 Warner-Lambert Company A process for the preparation of substantially alcohol free pharmaceutical compositions
DE4317320A1 (de) 1993-05-25 1994-12-01 Boehringer Mannheim Gmbh Neue Thiazolidindione und diese enthaltende Arzneimittel
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5536264A (en) * 1993-10-22 1996-07-16 The Procter & Gamble Company Absorbent composites comprising a porous macrostructure of absorbent gelling particles and a substrate
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
HU229200B1 (en) 1995-02-27 2013-09-30 Gilead Sciences Inc Selective inhibitors of viral or bacterial neuraminidase
CN100409844C (zh) 1995-02-27 2008-08-13 吉里德科学公司 神经氨酸苷酶抑制剂
DE69628007T2 (de) * 1995-06-07 2003-11-27 Elan Drug Delivery Ltd., Ruddington Verfahren zur stabilen einarbeitung von substanzen in trockene geschäumte glasmatrizen und auf diese weise hergestellte zusammensetzungen
US5763483A (en) 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
TR199802068T2 (xx) * 1996-04-16 2000-01-21 Novartis Consumer Health S.A. H�zl� b�l�nen oral doz formu.
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
BR9713258A (pt) * 1996-10-14 2000-03-28 Hoffmann La Roche Processo para a fabricação de uma preparação pulverosa
US6004996A (en) 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JPH11137208A (ja) 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
DK1071402T3 (da) * 1998-04-09 2007-02-19 Hoffmann La Roche Fremgangsmåde til af partikler med (sub)mikronstörrelse ved oplösning i komprimeret gas og overfladeaktive stoffer
DE69916288T2 (de) 1998-08-14 2005-03-24 F. Hoffmann-La Roche Ag Lipasehemmer und chitosan enthaltende arzneimittel
ATE293970T1 (de) 1998-08-14 2005-05-15 Hoffmann La Roche Lipasehemmer enthaltende pharmazeutische zusammensetzungen
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
US6342249B1 (en) * 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
GB9900416D0 (en) 1999-01-08 1999-02-24 Alizyme Therapeutics Ltd Inhibitors
EP1027886B1 (en) 1999-02-10 2008-07-09 Pfizer Products Inc. Pharmaceutical solid dispersions
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
FR2791569B1 (fr) * 1999-03-31 2003-05-09 Pf Medicament Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
JP4149803B2 (ja) * 2000-06-27 2008-09-17 エフ．ホフマン−ラ ロシュ アーゲー 組成物の調製方法

Also Published As

Publication number Publication date
ECSP024401A (es) 2003-02-06
YU96602A (sh) 2005-03-15
CZ2003212A3 (cs) 2003-06-18
CN1236764C (zh) 2006-01-18
HRP20021009B1 (hr) 2011-07-31
CA2411153C (en) 2007-01-30
AR029278A1 (es) 2003-06-18
ZA200209649B (en) 2004-03-10
MEP90608A (bs) 2011-12-20
KR20030023880A (ko) 2003-03-20
EG24141A (en) 2008-08-06
CZ301813B6 (cs) 2010-06-30
US20060134205A1 (en) 2006-06-22
WO2002000201A3 (en) 2002-04-18
DK1296656T3 (da) 2006-11-27
JP2007302683A (ja) 2007-11-22
SI1296656T1 (sl) 2006-12-31
MXPA02012583A (es) 2003-04-10
PL365803A1 (en) 2005-01-10
WO2002000201A2 (en) 2002-01-03
BR0112014A (pt) 2003-05-13
KR100557845B1 (ko) 2006-03-10
MA26922A1 (fr) 2004-12-20
TWI278325B (en) 2007-04-11
JP2004501184A (ja) 2004-01-15
JO2247B1 (en) 2004-10-07
PE20020101A1 (es) 2002-02-12
US20020018812A1 (en) 2002-02-14
IL153282A (en) 2008-03-20
EP1296656B1 (en) 2006-08-02
CA2411153A1 (en) 2002-01-03
HUP0302060A3 (en) 2006-07-28
IL153282A0 (en) 2003-07-06
EP1296656A2 (en) 2003-04-02
DE60121953D1 (de) 2006-09-14
PL203804B1 (pl) 2009-11-30
NZ523024A (en) 2004-08-27
CN1438880A (zh) 2003-08-27
PT1296656E (pt) 2006-12-29
MY129798A (en) 2007-04-30
AU2001281846B2 (en) 2006-04-27
NO20026197L (no) 2002-12-23
ES2269441T3 (es) 2007-04-01
RU2244542C2 (ru) 2005-01-20
ATE334662T1 (de) 2006-08-15
US7074431B2 (en) 2006-07-11
DE60121953T2 (de) 2007-03-08
BRPI0112014B1 (pt) 2016-09-13
HK1058314A1 (en) 2004-05-14
UY26799A1 (es) 2001-12-28
US20030039614A1 (en) 2003-02-27
AU8184601A (en) 2002-01-08
NO332181B1 (no) 2012-07-16
JP4149803B2 (ja) 2008-09-17
HRP20021009A2 (en) 2004-02-29
US6534087B2 (en) 2003-03-18
ME00672B (me) 2011-12-20
CY1105714T1 (el) 2010-12-22
HU229550B1 (en) 2014-01-28
HUP0302060A2 (hu) 2003-09-29

Similar Documents

Publication Publication Date Title
NO20026197D0 (no) Fremgangsmåte for fremstilling av en blanding
AU8178601A (en) Sustained release pharmaceutical compositions for the parenteral administration of biologically active hydrophilic compounds
DK1255534T3 (da) Fremgangsmåde til fremstilling af mikrokugler, der indeholder kolloide systemer
BR9503386A (pt) Formulaçao farmacêutica comprimido dispersivel e processo para a fabricaçao de comprimidos dispersíveis contendo cloridrato de fluoxetina
DK0831770T3 (da) Kontinuerlige fluorkemiske mikrodispersioner til afgivelse af farmaceutiske midler
EP1040823A3 (en) Stable foam compositions
ES2159564T3 (es) Preparados farmaceuticos para principios activos dificilmente solubles.
DK0973506T3 (da) Fremgangsmåde til fremstilling af faste farmaceutiske doseringsformer
MXPA02009275A (es) Metodo para preparar dispersiones de alta presion/alto esfuerzo cortante que contienen ingredientes fisiologicamente activos.
CU22836A3 (es) Sistema de gel de nimesulida para uso tópico
DK1267833T3 (da) Farmaceutiske præparater og fremgangsmåde til fremstilling deraf
ATE279414T1 (de) Verfahren zur herstellung von reinem triethylendiamin (teda)
DE60119905D1 (de) Verfahren zur herstellung fester dispersionen
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
WO2005046635A3 (de) Verfahren zur herstellung von lagerstabilen multiplen emulsionen
DE60104442D1 (de) Neue galenische dispergierbare und lösliche paracetamol-zubereitung, methode zu deren herstellung und deren anwendungen
SE0002354D0 (sv) New formulation
WO2002041875A3 (de) Verfahren zur herstellung leicht löslicher arzneimittelformulierungen und entsprechende formulierungen

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees